Skip to main content

G Samala

First name:
G
Last name:
Samala
Samala, G. ., Devi, B. ., Saxena, S. ., Gunda, S. ., Yogeeswari, P. ., & Sriram, D. . (2016). Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo 4,5 thieno 2,3-d pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry, 24(21), 5556-5564. https://doi.org/10.1016/j.bmc.2016.09.012 (Original work published 2016)
Samala, G. ., Devi, P. ., Saxena, S. ., Meda, N. ., Yogeeswari, P. ., & Sriram, D. . (2016). Design, synthesis and biological evaluation of imidazo 2,1-b thiazole and benzo d imidazo 2,1-b thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 24(6), 1298-307. https://doi.org/10.1016/j.bmc.2016.01.059 (Original work published 2016)
Saxena, S. ., Samala, G. ., Renuka, J. ., Sridevi, J. ., Yogeeswari, P. ., & Sriram, D. . (2015). Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain. Bioorganic & Medicinal Chemistry, 23(7), 1402-12. https://doi.org/10.1016/j.bmc.2015.02.032 (Original work published 2015)
Saxena, S. ., Samala, G. ., Sridevi, J. ., Devi, P. ., Yogeeswari, P. ., & Sriram, D. . (2015). Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors. European Journal of Medicinal Chemistry, 92, 401-14. https://doi.org/10.1016/j.ejmech.2014.12.046 (Original work published 2015)
Devi, P. ., Samala, G. ., Sridevi, J. ., Saxena, S. ., Alvala, M. ., Salina, E. ., … Yogeeswari, P. . (2014). Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. ChemMedChem, 9(11), 2538-47. https://doi.org/10.1002/cmdc.201402171
Samala, G. ., Nallangi, R. ., Devi, P. ., Saxena, S. ., Yadav, R. ., Sridevi, J. ., … Sriram, D. . (2014). Identification and development of 2-methylimidazo 1,2-a pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 22(15), 4223-32. https://doi.org/10.1016/j.bmc.2014.05.038 (Original work published 2014)
Samala, G. ., Kakan, S. ., Nallangi, R. ., Devi, P. ., Sridevi, J. ., Saxena, S. ., … Sriram, D. . (2014). Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione CD59 . International Journal of Mycobacteriology, 3(2), 117-26. https://doi.org/10.1016/j.ijmyco.2014.02.006
Samala, G. ., Devi, P. ., Nallangi, R. ., Sridevi, J. ., Saxena, S. ., Yogeeswari, P. ., & Sriram, D. . (2014). Development of novel tetrahydrothieno 2,3-c pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. Bioorganic & Medicinal Chemistry, 22(6), 1938-47. https://doi.org/10.1016/j.bmc.2014.01.030 (Original work published 2014)